Address	Technologiepark Heidelberg Baden Wuerttemberg 69120 Germany
Employees	-
Website	http://www.affimed.com
Updated	07/08/2019
Affimed NV is a clinical stage biopharmaceutical company, which engages in discovering and developing highly targeted cancer immunotherapies. The company has three proprietary platform technologies which includes: NK-cell TandAbs, T-cell TandAbs and Trispecific Abs. The company was founded in 2000 and is headquartered in Heidelberg, Germany.